Filing Details
- Accession Number:
- 0000908662-15-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-05 18:43:36
- Reporting Period:
- 2015-01-02
- Filing Date:
- 2015-01-05
- Accepted Time:
- 2015-01-05 18:43:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226283 | A Burt Adelman | C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756 | Cmo & Evp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-02 | 75,000 | $1.48 | 112,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-02 | 75,000 | $14.05 | 37,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-01-02 | 75,000 | $0.00 | 75,000 | $1.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 220,000 | 2022-02-24 | No | 4 | M | Direct |
Footnotes
- The sales reported in this form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2014.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.82 to $14.38, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within that range.
- Such option vests in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, which was February 24, 2012.
Billionaire Hedge Funds
